Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × Mass Screening × Clear all

Phase

Phase NA 21 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 361 Radiotherapy 234 fludarabine 205 Gemcitabine 180 Cisplatin 175 pembrolizumab 159 Nivolumab 158 Paclitaxel 154 Carboplatin 141 Magnetic Resonance Spectroscopy 138 fludarabine phosphate 134 Bevacizumab 112 Temozolomide 109 Irinotecan 109 Cytarabine 108 Specimen Handling 104 Capecitabine 104 Radiosurgery 103 Radiation 100 Docetaxel 100 Biopsy 94 Etoposide 93 Dexamethasone 92 Ipilimumab 91 Rituximab 90 Fluorouracil 89 Oxaliplatin 88 Filgrastim 86 Sorafenib 85 Lenalidomide 82

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00837135 2016-08-17

GI-4000 With Adoptive Transfer in Pancreatic Cancer

University of Pennsylvania

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡